
businessMay 12, 20264:50pending
Pantheon International chair Tony Morgan on shareholder return strategy
About this episode
Pantheon International PLC (LSE:PIN, FRA:PAA0) chair Tony Morgan tells Proactive's Stephen Gunnion that the company has completed a £224 million secondary portfolio sale and will use at least 80% of the proceeds - around £180 million - for share buybacks.
The numbers are striking: "Since 2022, PIN has returned over £350 million to shareholders and, following the completion of the buyback we've announced today, we expect this to exceed well over £500 million."
The sale is part of a strategic refocus around roughly 25 high-conviction private equity managers, down from around 90. The number of managers has already fallen to 62, with the portfolio sale completed at a blended discount to NAV of just over 8%.
For more videos from Proactive, visit the Proactive YouTube channel, like this video, subscribe to the channel and enable notifications so you never miss future updates.
#PantheonInternational #PrivateEquity #ShareBuyback #TonyMorgan #InvestmentTrust #PortfolioManagement #SecondaryMarket #ShareholderReturns #LSE #PrivateMarkets #CapitalManagement #Investing #FinanceNews #ProactiveInvestors #NAV
Get every episode summarized
Each time Proactive - Interviews for investors publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Proactive - Interviews for investors

Titan Minerals extends gold-silver mineralisation at Dynasty
Proactive - Interviews for investors
Sep 9, 20263:46failed

Krakatoa Resources: Zopkhito drilling extends gold-antimony potential
Proactive - Interviews for investors
Sep 9, 20264:07failed

Gaming Realms CEO: Content growth accelerating as company expands into new marke...
Proactive - Interviews for investors
Sep 9, 20262:59failed

genedrive CEO: NHS adoption and global expansion drive point-of-care testing pus...
Proactive - Interviews for investors
Sep 9, 20268:49failed